Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
NCT ID: NCT05359016
Last Updated: 2025-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
14600 participants
INTERVENTIONAL
2020-12-22
2027-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi
NCT04286243
Rice Technologies for Cervical Cancer Screening and Diagnosis
NCT05372484
Primary HPV-based Cervical Cancer Screening Algorithms in Botswana
NCT04242823
Prevention and Screening Towards Elimination of Cervical Cancer
NCT05234112
Simple Versus Radical Hysterectomy for Stage I Cervical Cancer
NCT00506376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study objectives are outlined below:
1. To quantify the health impact of CCS\&PT on the uptake of voluntary FP services.
2. To quantify the health impact of voluntary FP on the uptake of CCS\&PT services.
3. To determine which promotional strategies are most effective to increase uptake of CCS\&PT services.
4. To identify cost to deliver high quality CCS\&PT services integrated into existing voluntary FP programs.
5. To determine client and provider acceptability of integrated CCS\&PT and voluntary FP services using new screen and treat technologies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HPV testing of women for cervical cancer screening
Women enrolled in this study will receive HPV testing for cervical cancer screening. They will be offered self-sampling. And also they will be offered voluntary Family Planning services, as appropriate.
HPV testing of women for cervical cancer screening
Women enrolled in this study will receive HPV testing for cervical cancer screening. They will be offered self-sampling. And also they will be offered voluntary Family Planning services, as appropriate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HPV testing of women for cervical cancer screening
Women enrolled in this study will receive HPV testing for cervical cancer screening. They will be offered self-sampling. And also they will be offered voluntary Family Planning services, as appropriate.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not currently pregnant
* Patients with a cervix (women who have undergone a total hysterectomy with removal of the cervix are not eligible)
* Living in Maputo or Gaza
* Willing and able to provide informed consent for services.
* Physical or mental impairment that inhibits participation in the study
* Pregnant women
30 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Population Services International
OTHER
Eduardo Mondlane University
OTHER
William Marsh Rice University
OTHER
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen Schmeler, MD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2022-03767
Identifier Type: OTHER
Identifier Source: secondary_id
2020-0651
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.